Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 33.71M 39.33M 31.54M 28.83M 54.41M 3.77B 54.99M 373M 145M 1.89B 148M 144M 6.26B | P/E 2026 * |
-5.46x | P/E 2027 * | 38.3x |
|---|---|---|---|---|---|
| Enterprise Value | 33.71M 39.33M 31.54M 28.83M 54.41M 3.77B 54.99M 373M 145M 1.89B 148M 144M 6.26B | EV / Sales 2026 * |
11.2x | EV / Sales 2027 * | 3.37x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 39.35M | |
| -1.25% | +10.93% | +76.81% | +37.81% | 376B | |
| +0.33% | +1.47% | +25.82% | -13.90% | 70.02B | |
| +0.10% | +4.69% | +49.33% | +155.28% | 12.28B | |
| +0.10% | -0.02% | -2.27% | -1.83% | 8.49B | |
| +3.23% | -1.03% | -12.64% | +1.29% | 4.73B | |
| +2.43% | +0.72% | -26.70% | +18.02% | 4.43B | |
| -5.18% | -29.35% | -25.38% | +9.87% | 3.2B | |
| -1.74% | -6.65% | +1.42% | +42.32% | 2.67B | |
| -3.09% | -6.96% | -16.61% | -6.08% | 2.11B | |
| Average | -1.29% | +0.63% | +7.75% | +26.98% | 53.81B | |
| Weighted average by Cap. | -0.99% | +9.90% | +64.04% | +31.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3M 3.5M 2.81M 2.57M 4.84M 335M 4.89M 33.21M 12.91M 168M 13.14M 12.86M 557M | 10M 11.67M 9.36M 8.55M 16.14M 1.12B 16.31M 111M 43.04M 561M 43.81M 42.86M 1.86B |
| Net income | -6M -7M -5.61M -5.13M -9.68M -670M -9.79M -66.42M -25.83M -337M -26.29M -25.72M -1.11B | 1M 1.17M 936K 855K 1.61M 112M 1.63M 11.07M 4.3M 56.1M 4.38M 4.29M 186M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
